Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Braeburn receives complete response letter for Brixadi in the U.S.

Dec. 3, 2020

Nirsum Laboratories presents prodrugs of opioid receptor antagonists

Dec. 1, 2020

BP-C2 mitigates radiation-induced gastrointestinal syndrome in mice

Oct. 16, 2020

Selective PDEB inhibitor shows promising preclinical results for the treatment of cocaine addiction

Oct. 9, 2020

Sobrera and Recipharm collaborate on formulation development of SO-001 for alcohol use disorder

Sep. 29, 2020

Microglial pruning under the influence links alcohol to anxiety

Sep. 28, 2020

Proniras receives NIDA grant to pursue development of tezampanel for opioid withdrawal

Sep. 18, 2020

Embera begins phase II study of EMB-001 for cocaine use disorder

Sep. 1, 2020

FDA clears IND for phase II study of TNX-102 SL

Aug. 7, 2020

Indivior begins first-in-human study of INDV-2000 for opioid dependence

July 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...